BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 18268035)

  • 1. Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20.
    Turer EE; Tavares RM; Mortier E; Hitotsumatsu O; Advincula R; Lee B; Shifrin N; Malynn BA; Ma A
    J Exp Med; 2008 Feb; 205(2):451-64. PubMed ID: 18268035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium fortuitum induces A20 expression that impairs macrophage inflammatory responses.
    Lee GJ; Lee HM; Kim TS; Kim JK; Sohn KM; Jo EK
    Pathog Dis; 2016 Apr; 74(3):. PubMed ID: 26940588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice.
    Chu Y; Vahl JC; Kumar D; Heger K; Bertossi A; Wójtowicz E; Soberon V; Schenten D; Mack B; Reutelshöfer M; Beyaert R; Amann K; van Loo G; Schmidt-Supprian M
    Blood; 2011 Feb; 117(7):2227-36. PubMed ID: 21088135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals.
    Hitotsumatsu O; Ahmad RC; Tavares R; Wang M; Philpott D; Turer EE; Lee BL; Shiffin N; Advincula R; Malynn BA; Werts C; Ma A
    Immunity; 2008 Mar; 28(3):381-90. PubMed ID: 18342009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM.
    Hise AG; Daehnel K; Gillette-Ferguson I; Cho E; McGarry HF; Taylor MJ; Golenbock DT; Fitzgerald KA; Kazura JW; Pearlman E
    J Immunol; 2007 Jan; 178(2):1068-76. PubMed ID: 17202370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT1 plays a role in TLR signal transduction and inflammatory responses.
    Luu K; Greenhill CJ; Majoros A; Decker T; Jenkins BJ; Mansell A
    Immunol Cell Biol; 2014 Oct; 92(9):761-9. PubMed ID: 25027037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased A20-E3 ubiquitin ligase interactions in bid-deficient glia attenuate TLR3- and TLR4-induced inflammation.
    Kinsella S; Fichtner M; Watters O; König HG; Prehn JHM
    J Neuroinflammation; 2018 May; 15(1):130. PubMed ID: 29720226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.
    Boone DL; Turer EE; Lee EG; Ahmad RC; Wheeler MT; Tsui C; Hurley P; Chien M; Chai S; Hitotsumatsu O; McNally E; Pickart C; Ma A
    Nat Immunol; 2004 Oct; 5(10):1052-60. PubMed ID: 15334086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orphan Nuclear Receptor ERRα Controls Macrophage Metabolic Signaling and A20 Expression to Negatively Regulate TLR-Induced Inflammation.
    Yuk JM; Kim TS; Kim SY; Lee HM; Han J; Dufour CR; Kim JK; Jin HS; Yang CS; Park KS; Lee CH; Kim JM; Kweon GR; Choi HS; Vanacker JM; Moore DD; Giguère V; Jo EK
    Immunity; 2015 Jul; 43(1):80-91. PubMed ID: 26200012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity.
    Tavares RM; Turer EE; Liu CL; Advincula R; Scapini P; Rhee L; Barrera J; Lowell CA; Utz PJ; Malynn BA; Ma A
    Immunity; 2010 Aug; 33(2):181-91. PubMed ID: 20705491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b.
    Han C; Jin J; Xu S; Liu H; Li N; Cao X
    Nat Immunol; 2010 Aug; 11(8):734-42. PubMed ID: 20639876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-editing enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes.
    Wang J; Ouyang Y; Guner Y; Ford HR; Grishin AV
    J Immunol; 2009 Jul; 183(2):1384-92. PubMed ID: 19570823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A20 is an early responding negative regulator of Toll-like receptor 5 signalling in intestinal epithelial cells during inflammation.
    Oshima N; Ishihara S; Rumi MA; Aziz MM; Mishima Y; Kadota C; Moriyama I; Ishimura N; Amano Y; Kinoshita Y
    Clin Exp Immunol; 2010 Feb; 159(2):185-98. PubMed ID: 19912257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of the ubiquitin-editing enzyme A20 results in loss of hematopoietic stem cell quiescence.
    Nakagawa MM; Thummar K; Mandelbaum J; Pasqualucci L; Rathinam CV
    J Exp Med; 2015 Feb; 212(2):203-16. PubMed ID: 25624445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ubiquitin-Modifying Enzyme A20 Terminates C-Type Lectin Receptor Signals and Is a Suppressor of Host Defense against Systemic Fungal Infection.
    Liang J; Zhang JJ; Huang HI; Kanayama M; Youssef N; Jin YJ; Reyes EY; Abram CL; Yang S; Lowell CA; Wang D; Shao L; Shinohara ML; Zhang JY; Hammer GE
    Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32540868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A20 expression in dendritic cells protects mice from LPS-induced mortality.
    Xuan NT; Wang X; Nishanth G; Waisman A; Borucki K; Isermann B; Naumann M; Deckert M; Schlüter D
    Eur J Immunol; 2015 Mar; 45(3):818-28. PubMed ID: 25472594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells.
    Giordano M; Roncagalli R; Bourdely P; Chasson L; Buferne M; Yamasaki S; Beyaert R; van Loo G; Auphan-Anezin N; Schmitt-Verhulst AM; Verdeil G
    Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11115-20. PubMed ID: 25024217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis.
    Vereecke L; Sze M; Mc Guire C; Rogiers B; Chu Y; Schmidt-Supprian M; Pasparakis M; Beyaert R; van Loo G
    J Exp Med; 2010 Jul; 207(7):1513-23. PubMed ID: 20530205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulator of calcineurin 1 differentially regulates TLR-dependent MyD88 and TRIF signaling pathways.
    Pang Z; Junkins RD; Raudonis R; MacNeil AJ; McCormick C; Cheng Z; Lin TJ
    PLoS One; 2018; 13(5):e0197491. PubMed ID: 29799862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease.
    Asquith MJ; Boulard O; Powrie F; Maloy KJ
    Gastroenterology; 2010 Aug; 139(2):519-29, 529.e1-2. PubMed ID: 20433840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.